Donate now!

Philanthropy is crucial to support our mission and serve our patients. Every gift counts, no matter the size. Below you can find a list of recent publications by our talented and diverse faculty. Click here to contribute! Thank you for your consideration.

Recent Publications

• Priorities to Improve Caregiving Experiences in Parkinson Disease: A Qualitative Study of Multiple Stakeholders.
  Seshadri S, Ferrell B, Aamodt WW, Contento A, Kluger BM Neurology. Clinical practice. 2026 Oct;16(5):e200649 Epub 2026 Jul 21;
• Activated microglial phenotypes in the hippocampal CA2 subfield are implicated in Lewy body disease progression.
  Luna E, Cousins KAQ, Emrani S, Xie SX, Trotman W, Capp N, Sabatini P, Pouladvand P, Suh E, Van Deerlin VM, Weintraub D, Chen-Plotkin AS, Lee EB, Irwin DJ Acta neuropathologica. 2026 Aug 8;152(1);
• Diffusion MRI and α-Synuclein Seed Amplification Status in Parkinson's Disease.
  Chiu SY, Wang WE, Chen R, DeSimone JC, Archer DB, Adler CH, Mehta SH, Dresler SR, Armstrong MJ, McFarland N, Okun M, Vaillancourt DE, Parkinson's Progression Markers Initiative Annals of neurology. 2026 Aug;100(2):295-304 Epub 2026 May 7;
• Pathology and Genetics in a Global Cohort of Parkinsonian Disorders.
  Wu LY, du Toit T, Georgiades T, Stafford EJ, Levine K, Fang ZH, Jasaityte S, Martinez AG, Cullinane P, De Pablo-Fernandez E, Blauwendraat C, Singleton AB, Scholz SW, Traynor BJ, Wood N, Hardy J, Chinnery P, Houlden H, Cain R, Troakes C, Chelban V, Serrano GE, Gveric D, McLean C, Love S, King A, Robinson AC, Roncaroli F, Shepherd C, Halliday G, Parkkinen L, Morris CM, Smith C, Beach TG, Gentleman S, Warner TT, Lashley T, Jaunmuktane Z, Real R, Morris HR, Global Parkinson’s Genetic Program (GP2) JAMA neurology. 2026 Aug 1;83(8):798-807;
• Increased Serum Neurofilament Light Chain Levels in Parkinson's Disease Patients Carrying the p.A53T SNCA Mutation: Data from the Parkinson's Progression Markers Initiative Study.
  Papagiannakis N, Koros C, Simitsi AM, Stefanis L, and The Parkinson's Progression Markers Initiative Movement disorders : official journal of the Movement Disorder Society. 2026 Jun;41(6):1580-1585 Epub 2026 Feb 23;
• Temporal Modeling of Amyloid and Tau Trajectories in Alzheimer's Disease Using PET and Plasma Biomarkers.
  Brown CA, Cousins KAQ, Korecka M, McGrew E, Chen-Plotkin A, Detre JA, McMillan CT, Lee EB, Das SR, Mechanic-Hamilton D, Yushkevich PA, Nasrallah IM, Shaw LM, Alzheimer's Disease Neuroimaging Initiative, Wolk DA Annals of neurology. 2026 Jun;99(6):1438-1451 Epub 2026 Mar 15;
• Association between Plasma P-tau217 and Alzheimer's Copathology and Cognitive Decline in Parkinson's Disease.
  Tropea TF, Stevenson PA, Flitter M, Meehan D, Morris A, Lu M, Iaccarino L, Collins EC, Hodsdon ME, Irwin D, Spindler M, Deik A, Dahodwala N, Cousins KAQ, Wolk DA, Shaw L, Weintraub D, Lee EB, Chen-Plotkin A, Mintun M, Siderowf A Annals of neurology. 2026 Jun;99(6):1428-1437 Epub 2026 Mar 18;
• Safety and efficacy of the anti-α-synuclein monoclonal antibody amlenetug for the treatment of patients with multiple system atrophy (AMULET): a phase 2, randomised, double-blind, multicentre trial.
  Kjærsgaard L, Wiedemann J, Singer W, Takeda A, Berger AK, Flensburg MF, Hansen L, Kallunki P, Kompus K, Nighah K, Schmidt SN, Jørgensen MN, Svanholm Fogh B, Zanigni S, Luthman J, AMULET Trial Group The Lancet. Neurology. 2026 Jun;25(6):560-570 Epub 2026 Apr 24;
• Secreted GPNMB enhances uptake of fibrillar alpha-synuclein in a non-cell-autonomous process that can be blocked by anti-GPNMB antibodies.
  Carceles-Cordon M, Brody EM, Boucher ML, Gallagher MD, Skrinak RT, Unger TL, Penner CK, Berndt AJ, Das S, Lam K, Jaenisch R, Van Deerlin V, Lee EB, Brunden K, Luk KC, Chen-Plotkin AS Neuron. 2026 May 12;
• Sex Differences in Fall Frequency, Risk Factors, and Outcomes in Parkinson's Disease: A Cross-Sectional Analysis.
  Vizcarra JA, Hefter K, Lafontant DE, Duong MT, Ertefaie A, Litt B, Bassett DS, Siderowf A, Parkinson's Progression Markers Initiative Movement disorders clinical practice. 2026 May 7;
• Large-scale genetic characterization of Parkinson's disease in the African and African admixed populations.
  Akçimen F, Paquette K, Wild Crea P, Step K, Waldo E, Koretsky MJ, Saffie-Awad P, Achoru C, Taiwo F, Ozomma S, Onwuegbuzie G, Khani M, Grant S, Owolabi L, Okereke C, Oshinaike O, Iwuozo E, Akerman SC, Lee PS, Oyakhire S, Osemwegie N, Daida K, Abubakar S, Olusanya A, Isayan M, Alvarez C, Traurig R, Ogunmodede A, Samuel S, Makarious MB, Sa'ad F, Olanigan R, Levine K, Ogbimi EM, Vitale D, Odiase F, Ojini F, Odeniyi O, Fang ZH, Obianozie N, Hall DA, Nwazor E, Xie T, Nwaokorie F, Padmanaban M, Nwani P, Shamim EA, Nnama A, Standaert D, Komolafe M, Dean M, Osaigbovo G, Disbrow E, Ishola I, Rawls A, Imarhiagbe F, Chandra S, Erameh C, Hinson V, Louie N, Idowu A, Solle J, Norris SA, Ibrahim A, Kilbane C, Sukumar G, Shulman LM, Ezuduemoih D, Staisch J, Breaux S, Dalgard C, Foster ER, Bello A, Ameri A, Real R, Ikwenu E, Morris HR, Anyanwu R, Furr Stimming E, Billingsley K, Alaofin W, Alvarez Jerez P, Agabi O, Hernandez DG, Akinyemi R, Arepalli S, Malik L, Owolabi R, Nyandaiti Y, Leonard HL, Wahab K, Abiodun O, Hernandez CF, Abdulai F, Iwaki H, Bardien S, Klein C, Hardy J, Houlden H, Galvelis KG, Nalls MA, Dahodwala N, Aamodt W, Hill E, Espay A, Factor S, Branson C, Blauwendraat C, Singleton AB, Ojo O, Chahine LM, Okubadejo N, Bandres-Ciga S Brain : a journal of neurology. 2026 May 5;149(5):1537-1553;
• Genome-Wide Assessment Reveals Ancestral Differences in Homozygosity Patterns Potentially Linked to Parkinson's Disease Etiology.
  Step K, Hernández CF, Khani M, Eltaraifee E, Hernández-Medrano AJ, Kung PJ, Ostrožovičová M, Zirra A, Pérez-Palma E, Mencacci NE, Keller Sarmiento IJ, Morris HR, Mata IF, Acosta-Uribe J, Fang ZH, Bandres-Ciga S, Global Parkinson's Genetics Program (GP2) Movement disorders : official journal of the Movement Disorder Society. 2026 May;41(5):1128-1140 Epub 2026 Mar 11;
• True vignettes: interesting, illustrative examples of behavioral abnormalities in people with Parkinson's disease.
  Friedman JH, Akbar U, Beehler B, Chou KL, Cloud LJ, Deik A, Gilbert R, Gomperts SN, Goudreau JL, Gunzler SA, Lizarraga K, Malaty I, Maurer CW, Miyasaki J, Mohammed N, Morgan JC, Munhoz RP, Pal G, Shulman L, Simon D, Pontone G Arquivos de neuro-psiquiatria. 2026 May;84(5):1-6 Epub 2026 May 18;
• Discordance of Dopaminergic Dysfunction and Subcortical Atrophy by α-Synuclein Status in Sporadic and Genetic Parkinson's Disease.
  Duong MT, Das SR, Khandelwal P, Vizcarra JA, Li Y, Xie L, Yushkevich PA, Shaw LM, Dubroff JG, Parkinson's Progression Markers Initiative, Siderowf A, Wolk DA, Nasrallah IM Movement disorders : official journal of the Movement Disorder Society. 2026 May;41(5):1101-1113 Epub 2026 Jan 28;
• Medial temporal lobe Tau-Neurodegeneration mismatch from structural imaging and plasma biomarkers.
  Lyu X, Mundada NS, Brown CA, Sadeghpour N, McGrew E, Xie L, Li Y, Wuestefeld A, Duong MT, Cook P, Gee J, Nasrallah IM, Chen-Plotkin AS, Shaw LM, Mechanic-Hamilton D, Wisse LEM, Yushkevich PA, Das SR, Wolk DA Brain : a journal of neurology. 2026 Apr 28;
• Partnering With Participant Advisors on the Parkinson's Progression Markers Initiative.
  McGuire Kuhl M, Destro C, Dobkin RD, Tropea TF, Brodkin K, Flagg E, Lemon LP, Henry B, McMahon BA, Stanley CE Jr, Matthews-McGee A, Heathers LEA, Miller M, Myers H, Foroud T, Pico C, Kelliher C, Kopil CM, Dance A, Duggan B, Goldstein FS, Robinson BS, Robinson J, Acevedo M, Clark M, Hidaka C, Moran J, Lugo P, Sugihara S, Paulson RD, Alongi PT, Comerci L, Kwok K, Kramer H, Marek K, Parkinson's Progression Markers Initiative Annals of neurology. 2026 Apr 21;
• Developing a Virtual Research Environment in the Parkinson's Progression Markers Initiative: myPPMI.
  Stanley CE Jr, Fabrizio K, McMahon BA, Matthews-McGee A, Fitzgerald C, Singh Z, Rigby NH, Talarico JM, Brown EG, Korell M, McGuire Kuhl M, Destro C, Pavese N, Garrido A, Mollenhauer B, Chowdhury S, Marek K, Tanner CM, Tropea TF, Parkinson's Progression Markers Initiative Annals of neurology. 2026 Apr 21;
• Clinical Progression in Alpha-Synuclein Positive LRRK2-PD and Sporadic Parkinson's Disease: A Longitudinal Analysis.
  Morse LA, Choi SH, Gochanour C, Lafontant DE, Chahine LM, Merchant KM, Wendelberger B, Simuni T, Parkinson's Progression Markers Initiative Movement disorders clinical practice. 2026 Apr 19;
• Teaching Video NeuroImage: C9orf72-Related Parkinsonism.
  Super M, Paul RA, Irwin DJ, Aamodt WW Neurology. 2026 Apr 14;106(7):e214828 Epub 2026 Mar 17;
• Toward Harmonizing Quantification of Dopamine Neuron Imaging Biomarkers in Parkinson's Disease: The Centamine Scale.
  Fan Z, Searle G, Rizzo G, Albani J, Cella P, Comley R, Klein G, Passamonti L, Salinas C, Schwarz AJ, Iaccarino L, Tamagnan G, Eberling J, Marek K, Seibyl J, Gunn RN, Parkinson's Progression Markers Initiative Annals of neurology. 2026 Apr;99(4):949-963 Epub 2026 Jan 20;
• The Impact of Participation in the Parkinson's Pals Program on Psychosocial Symptoms in Parkinson's Disease: An Unblinded Feasibility Study.
  Gujral J, Garg U, Gandhi OH, Eickholt L, Aamodt WW Movement disorders clinical practice. 2026 Apr 1;
• Delphi consensus guidelines for the use of striatal dopaminergic imaging and cardiac metaiodobenzylguanidine (MIBG) scintigraphy for the diagnosis of dementia and mild cognitive impairment with Lewy bodies.
  Donaghy PC, Greenfinch G, Petrides G, Kane J, Verberne HJ, Taylor JP, O'Brien JT, Thomas AJ, DLB Indicative Imaging Biomarker Study Group Alzheimer's & dementia (Amsterdam, Netherlands). 2026 Jan-Mar;18(1):e70296 Epub 2026 Mar 4;
• Recruitment strategies for the racial disparities in Parkinson's disease study: Partnering with patients from the Black community.
  Vanegas J, Weimer R, Krinickas N, Hall DA, Shulman LM, RaD-PD Study Group Parkinsonism & related disorders. 2026 Mar;144:108173 Epub 2025 Dec 31;
• Microglia protein profiles in CSF across Alzheimer's disease clinical stages.
  Blujdea ER, van Bokhoven P, Martino-Adami PV, Marshe VS, Vromen EM, Hok-A-Hin YS, Boiten WA, Irwin DJ, Chen-Plotkin AS, Lemstra AW, Pijnenburg Y, van der Flier WM, Peters O, Hellmann-Regen J, Priller J, Schneider A, Wiltfang J, Jessen F, Düzel E, Buerger K, Perneczky R, Teipel S, Laske C, Brosseron F, DELCODE Consortium, Del Campo M, Wijdeven R, Visser PJ, Tijms BM, De Jager PL, Ramirez A, Teunissen CE, Vermunt L Nature aging. 2026 Mar;6(3):520-533 Epub 2026 Mar 11;
• A Holistic Wellness Prescription for Parkinson's Disease: Evidence-Based Perspectives and Unmet Needs.
  Subramanian I, Ricciardi L, Schrag A, Appel-Cresswell S, Kola S, Domingos JM, Pickut BA, Dahodwala N, Bocoum A, Falup-Pecurariu C, Bronner G, Pontone GM, Mischley LK, Garretto NS, Modugno N, Dolhun R, Wijeratne T, Tull V, McDaniels B, Chaudhuri KR, International Parkinson, Movement Disorder Society Task Force on Wellness Movement disorders clinical practice. 2026 Mar;13(3):631-646 Epub 2025 Oct 14;
• Microglial reactivity in the hippocampal CA2 is associated with advanced neuronal α-synucleinopathy.
  Luna E, Cousins KAQ, Emrani S, Xie SX, Trotman W, Weintraub D, Chen-Plotkin AS, Lee EB, Irwin DJ bioRxiv : the preprint server for biology. 2026 Feb 11;
• Evaluation of Copathology and Clinical Trajectories in Individuals With Tau-Clinical Mismatch.
  Brown CA, Mundada NS, Cousins KAQ, Sadeghpour N, Lyu X, McGrew E, Korecka M, Chen-Plotkin A, Xie L, Wisse LEM, Detre JA, McMillan CT, Lee EB, Nasrallah IM, Das SR, Mechanic-Hamilton D, Yushkevich PA, Shaw LM, Wolk DA, Alzheimer’s Disease Neuroimaging Initiative JAMA neurology. 2026 Feb 1;83(2):126-136;
• The Role of AI in the Management of Movement Disorders.
  Deik A Seminars in neurology. 2026 Feb;46(1):77-85 Epub 2025 Apr 29;
• Secreted GPNMB enhances uptake of fibrillar alpha-synuclein in a non-cell-autonomous process that can be blocked by anti-GPNMB antibodies.
  Carceles-Cordon M, Brody EM, Boucher ML, Gallagher MD, Skrinak RT, Unger TL, Penner CK, Berndt AJ, Das S, Lam K, Jaenisch R, Van Deerlin V, Lee EB, Brunden K, Luk K, Chen-Plotkin AS medRxiv : the preprint server for health sciences. 2026 Jan 28;
• Evaluating multivariable prediction models for Parkinson's disease prognosis: a scoping review protocol.
  Eickholt L, Super M, Aamodt W BMJ open. 2025 Dec 29;15(12):e107156;
• Longitudinal Study of Treatment Variability for Parkinson's Disease across Specialized Centers.
  Dahodwala N, Kapogiannis T, Cruz A, Beck JC, Davis TL, Liu H, Luo S, Naito A, Neault M, Rafferty MR, Ramirez-Zamora A, Marras C Movement disorders clinical practice. 2025 Dec;12(12):2207-2216 Epub 2025 Jul 15;
• Mapping the developmental path for Parkinson's disease therapeutics.
  Dhruv NT, Robinson Schwartz S, Swanson-Fischer C, Cho HJ, Corlew R, Jakeman L, Laboissonniere LA, Price R, Sarraf S, Sieber BA, Torborg C, Wonders C, Chen-Plotkin A, Martin WJ, Tamiz AP NPJ Parkinson's disease. 2025 Nov 7;11(1):313;
• Blood α-Synuclein Separates Parkinson's Disease from Dementia with Lewy Bodies.
  Kannarkat GT, Zack R, Skrinak RT, Morley JF, Davila-Rivera R, Arezoumandan S, Dorfman K, Luk K, Wolk DA, Weintraub D, Tropea TF, Lee EB, Xie SX, Chandrasekaran G, Lee VM, Irwin D, Akhtar RS, Chen-Plotkin AS Annals of neurology. 2025 Oct;98(4):682-698 Epub 2025 Jun 16;
• Percentile scores for the revised University of Pennsylvania Smell Identification Test for 16,972 individuals 60 years of age and older.
  Pierz KA, Aamodt W, Gochanour C, Kurth R, Brumm MC, Coffey CS, Heathers LE, Totten M, Doty RL, Marek K, Siderowf A, Parkinson’s Progression Markers Initiative NPJ Parkinson's disease. 2025 Oct 1;11(1):280;
• Temporal Modeling of Amyloid and Tau Trajectories in Alzheimer's Disease using PET and Plasma Biomarkers.
  Brown CA, Cousins KAQ, Korecka M, McGrew E, Chen-Plotkin A, Detre JA, McMillan CT, Lee EB, Das SR, Mechanic-Hamilton D, Yushkevich PA, Nasrallah IM, Shaw LM, Alzheimer’s Disease Neuroimaging Initiative, Wolk DA medRxiv : the preprint server for health sciences. 2025 Sep 7;
• Sex and Racial/Ethnic Differences in End-of-Life Care Preferences in Persons with Parkinson's Disease and Related Disorders.
  Aamodt WW, Eickholt L, Coughlin DG, Solomon L, Rendle KA, Marshall C, Vizcarra JA, Dahodwala N Movement disorders : official journal of the Movement Disorder Society. 2025 Sep;40(9):1951-1964 Epub 2025 May 23;
• Care partner needs in Parkinson's disease: A systematic review of qualitative and quantitative data.
  Hulshoff M, Sun C, Book E, Tanner C, Dahodwala N, Reynolds B, Boon H, Marras C Journal of Parkinson's disease. 2025 Sep;15(6):1043-1061 Epub 2025 May 30;
• Contributors to Gender Disparities in Parkinson's Disease Caregiving.
  Horn S, Dai Y, Wu SS, Dahodwala N Journal of geriatric psychiatry and neurology. 2025 Sep;38(5):394-404 Epub 2025 Mar 21;
• Facets of Religion/Spirituality and Cognitive Health: Association Variations Across Gender and Race Among Older Adults.
  Britt KC, Obeng Boateng AC, Nwadiogbu C, Ashida S, Tranel D, Thorpe RJ Jr, Dahodwala N Religions. 2025 Sep;16(9) Epub 2025 Sep 19;
• Large-scale CSF proteome profiling identifies biomarkers for accurate diagnosis of frontotemporal dementia.
  Hok-A-Hin YS, Vermunt L, Peeters CFW, van der Ende EL, de Boer SCM, Meeter LH, de Houwer J, Seelaar H, van Swieten JC, Hu WT, Lleó A, Alcolea D, Engelborghs S, Sieben A, Chen-Plotkin A, Irwin DJ, van der Flier WM, Pijnenburg YAL, Teunissen CE, Del Campo M Molecular neurodegeneration. 2025 Aug 27;20(1):93;
• Medial temporal lobe Tau-Neurodegeneration mismatch from MRI and plasma biomarkers identifies vulnerable and resilient phenotypes with AD.
  Lyu X, Mundada NS, Brown CA, Sadeghpour N, McGrew E, Xie L, Li Y, Wuestefeld A, Duong MT, Cook P, Gee J, Nasrallah IM, Chen-Plotkin AS, Shaw LM, Mechanic-Hamilton D, Wisse LEM, Yushkevich PA, Das SR, Wolk DA, Alzheimer’s Disease Neuroimaging Initiative medRxiv : the preprint server for health sciences. 2025 Aug 19;
• Author Correction: Time-to-event analysis mitigates the impact of symptomatic therapy on therapeutic benefit in Parkinson's disease trials.
  Pagano G, Trundell D, Simuni T, Pavese N, Marek K, Postuma RB, Shariati N, Monnet A, Moore E, Davies EW, Svoboda H, Pross N, Bonni A, Nikolcheva T, PASADENA Investigators, Prasinezumab Study Group NPJ Parkinson's disease. 2025 Aug 13;11(1):241;
• Triglyceride-glucose index predicts cognitive decline and striatal dopamine deficiency in Parkinson disease in two cohorts.
  Cao H, Zhao Y, Chen Z, Zou X, Du X, Yi L, Ai Y, Zuo H, Cheng O, Parkinson’s Progression Markers Initiative NPJ Parkinson's disease. 2025 Aug 13;11(1):240;
• Genetic Diversity and Expanded Phenotypes in Dystonia: Insights From Large-Scale Exome Sequencing.
  Thomsen M, Ott F, Loens S, Kilic-Berkmen G, Tan AH, Lim SY, Lohmann E, Schröder KM, Ipsen L, Nothacker LA, Welzel L, Rudnik AS, Hinrichs F, Odorfer T, Zeuner KE, Schumann F, Kühn AA, Zittel S, Moeller M, Pfister R, Kamm C, Lang AE, Tay YW, de Almeida Marcelino AL, Vidailhet M, Roze E, Perlmutter JS, Feuerstein JS, Fung VSC, Chang F, Barbano RL, Bellows S, Wagle Shukla AA, Espay AJ, LeDoux MS, Berman BD, Reich S, Deik A, Franke A, Wittig M, Franzenburg S, Volkmann J, Brüggemann N, Jinnah HA, Bäumer T, Klein C, Busch H, Lohmann K Annals of clinical and translational neurology. 2025 Aug;12(8):1648-1659 Epub 2025 Jun 18;
• Tau-Clinical Mismatch Identifies Individuals with Co-Pathology and Predicts Clinical Trajectory.
  Brown CA, Mundada NS, Cousins KAQ, Sadeghpour N, Lyu X, McGrew E, Korecka M, Chen-Plotkin A, Xie L, Wisse LEM, Detre JA, McMillan CT, Lee EB, Nasrallah IM, Das SR, Mechanic-Hamilton D, Yushkevich PA, Shaw LM, Alzheimer’s Disease Neuroimaging Initiative, Wolk DA medRxiv : the preprint server for health sciences. 2025 Jul 25;
• Time-to-event analysis mitigates the impact of symptomatic therapy on therapeutic benefit in Parkinson's disease trials.
  Pagano G, Trundell D, Simuni T, Pavese N, Marek K, Postuma RB, Shariati N, Monnet A, Moore E, Davies EW, Svoboda H, Pross N, Bonni A, Nikolcheva T, PASADENA Investigators, Prasinezumab Study Group NPJ Parkinson's disease. 2025 Jul 1;11(1):193;
• Neuronal α-Synuclein Disease Stage Progression over 5 Years.
  Simuni T, Gochanour C, Nair AR, Brumm MC, Coffey C, Poston KL, Chahine LM, Weintraub D, Tanner CM, Gonzalez-Latapi P, Kopil CM, Xiao Y, Chowdhury S, Dam T, Pagano G, Stephenson D, Siderowf A, Dunn B, Marek K, NSD Working Group the Parkinson's Progression Markers Initiative Movement disorders : official journal of the Movement Disorder Society. 2025 Jul;40(7):1318-1330 Epub 2025 Apr 30;
• Exploratory digital outcome measures of motor sign progression in Parkinson's disease patients treated with prasinezumab.
  Taylor KI, Lipsmeier F, Scelsi MA, Volkova-Volkmar E, Rukina D, Popp W, Lambrecht S, Anzures-Cabrera J, Summers D, Abt M, Monnet A, Kilchenmann T, Schjodt-Eriksen J, Essioux L, Kustermann T, Zago W, Svoboda H, Nikolcheva T, Postuma RB, Pagano G, Lindemann M, PASADENA Investigators, Prasinezumab Study Group NPJ digital medicine. 2025 Jun 16;8(1):365;
• Calcium modulating ligand confers risk for Parkinson's disease and impacts lysosomes.
  Zhang H, Kargilis D, Tropea T, Robinson J, Shen J, Brody EM, Brinkmalm A, Sjödin S, Berndt AJ, Carceles-Cordon M, Suh E, Van Deerlin VM, Blennow K, Weintraub D, Lee EB, Zetterberg H, Chen-Plotkin AS Annals of clinical and translational neurology. 2025 May;12(5):925-937 Epub 2025 Mar 7;
• Parkinson's disease is characterized by vitamin B6-dependent inflammatory kynurenine pathway dysfunction.
  Wilson EN, Umans J, Swarovski MS, Minhas PS, Mendiola JH, Midttun Ø, Ulvik A, Shahid-Besanti M, Linortner P, Mhatre SD, Wang Q, Channappa D, Corso NK, Tian L, Fredericks CA, Kerchner GA, Plowey ED, Cholerton B, Ueland PM, Zabetian CP, Gray NE, Quinn JF, Montine TJ, Sha SJ, Longo FM, Wolk DA, Chen-Plotkin A, Henderson VW, Wyss-Coray T, Wagner AD, Mormino EC, Aghaeepour N, Poston KL, Andreasson KI NPJ Parkinson's disease. 2025 Apr 26;11(1):96;
• Neuroimaging-based data-driven subtypes of spatiotemporal atrophy due to Parkinson's disease.
  Shawa Z, Shand C, Taylor B, Berendse HW, Vriend C, van Balkom TD, van den Heuvel OA, van der Werf YD, Wang JJ, Tsai CC, Druzgal J, Newman BT, Melzer TR, Pitcher TL, Dalrymple-Alford JC, Anderson TJ, Garraux G, Rango M, Schwingenschuh P, Suette M, Parkes LM, Al-Bachari S, Klein J, Hu MTM, McMillan CT, Piras F, Vecchio D, Pellicano C, Zhang C, Poston KL, Ghasemi E, Cendes F, Yasuda CL, Tosun D, Mosley P, Thompson PM, Jahanshad N, Owens-Walton C, d'Angremont E, van Heese EM, Laansma MA, Altmann A, ENIGMA Parkinson’s Disease Working Group, Weil RS, Oxtoby NP Brain communications. 2025;7(2):fcaf146 Epub 2025 Apr 16;
• An Open-Label Pilot Study to Examine the Safety, Tolerability and Efficacy of Deutetrabenazine in Isolated Dystonia.
  Deik A, Aamodt W, Cadet C, Lasker A, Oliver A, Spindler M, Tropea TF, Vaswani P, Siderowf A Movement disorders clinical practice. 2025 Apr;12(4):504-509 Epub 2025 Jan 4;
• LRRK2-associated parkinsonism with and without in vivo evidence of alpha-synuclein aggregates: longitudinal clinical and biomarker characterization.
  Chahine LM, Lafontant DE, Choi SH, Iwaki H, Blauwendraat C, Singleton AB, Brumm MC, Alcalay RN, Merchant K, Nudelman KNH, Dagher A, Vo A, Tao Q, Venuto CS, Kieburtz K, Poston KL, Bressman S, Gonzalez-Latapi P, Avants B, Coffey C, Jennings D, Tolosa E, Siderowf A, Marek K, Simuni T, Parkinson’s Progression Markers Initiative Brain communications. 2025;7(2):fcaf103 Epub 2025 Mar 6;
• Correlation of the clinical rating scale for tremor with a global assessment.
  Howard SD, Singh S, Macaluso D, Hsu JY, Cajigas I, Qiu L, Halpern CH, Aamodt WW, Farrar JT Clinical neurology and neurosurgery. 2025 Feb;249:108710 Epub 2024 Dec 24;
• Large-scale genetic characterization of Parkinson's disease in the African and African admixed populations.
  Akçimen F, Paquette K, Crea PW, Saffie-Awad P, Achoru C, Taiwo F, Ozomma S, Onwuegbuzie G, Khani M, Grant S, Owolabi L, Okereke C, Oshinaike O, Iwuozo E, Lee PS, Oyakhire S, Osemwegie N, Daida K, Abubakar S, Olusanya A, Isayan M, Traurig R, Ogunmodede A, Samuel S, Makarious MB, Sa'ad F, Olanigan R, Levine K, Ogbimi EM, Vitale D, Odiase F, Koretsky MJ, Ojini F, Odeniyi O, Fang ZH, Obianozie N, Hall DA, Nwazor E, Xie T, Nwaokorie F, Padmanaban M, Nwani P, Shamim EA, Nnama A, Standaert D, Komolafe M, Dean M, Osaigbovo G, Disbrow E, Ishola I, Rawls A, Imarhiagbe F, Chandra S, Erameh C, Hinson V, Louie N, Idowu A, Solle J, Norris SA, Ibrahim A, Kilbane C, Sukumar G, Shulman LM, Ezuduemoih D, Staisch J, Breaux S, Dalgard C, Foster ER, Bello A, Ameri A, Real R, Ikwenu E, Morris HR, Anyanwu R, Stimming EF, Billingsley K, Alaofin W, Jerez PA, Agabi O, Hernandez DG, Akinyemi R, Arepalli S, Malik L, Owolabi R, Nyandaiti Y, Leonard HL, Wahab K, Step K, Abiodun O, Hernandez CF, Abdulai F, Iwaki H, Bardien S, Klein C, Hardy J, Houlden H, Galvelis KG, Nalls MA, Dahodwala N, Aamodt W, Hill E, Espay A, Factor S, Branson C, Blauwendraat C, Singleton AB, Ojo O, Chahine LM, Black and African American Connections to Parkinson’s Disease Study (BLAAC PD), Nigeria Parkinson’s Disease Research Network (NPDRN), Racial Disparities in Parkinson Disease (RaD-PD), Global Parkinson’s Genetics Program (GP2), Okubadejo N, Bandres-Ciga S medRxiv : the preprint server for health sciences. 2025 Jan 20;
• ADNI Biomarker Core: A review of progress since 2004 and future challenges.
  Shaw LM, Korecka M, Lee EB, Cousins KAQ, Vanderstichele H, Schindler SE, Tosun D, DeMarco ML, Brylska M, Wan Y, Burnham S, Sciulli A, Vulaj A, Tropea TF, Chen-Plotkin A, Wolk DA, Alzheimer's Disease Neuroimaging Initiative Alzheimer's & dementia : the journal of the Alzheimer's Association. 2025 Jan;21(1):e14264 Epub 2024 Nov 30;
• Genetic Diversity and Expanded Phenotypes in Dystonia: Insights from Large-Scale Exome Sequencing.
  Thomsen M, Ott F, Loens S, Kilic-Berkmen G, Tan AH, Lim SY, Lohmann E, Schröder KM, Ipsen L, Nothacker LA, Welzel L, Rudnik AS, Hinrichs F, Odorfer T, Zeuner KE, Schumann F, Kühn AA, Zittel S, Moeller M, Pfister R, Kamm C, Lang AE, Tay YW, Vidailhet M, Roze E, Perlmutter JS, Feuerstein JS, Fung VSC, Chang F, Barbano RL, Bellows S, Shukla AAW, Espay AJ, LeDoux MS, Berman BD, Reich S, Deik A, Franke A, Wittig M, Franzenburg S, Volkmann J, Brüggemann N, Jinnah HA, Bäumer T, Klein C, Busch H, Lohmann K medRxiv : the preprint server for health sciences. 2024 Dec 5;
• "Reply: Improving Insight and Application: A Commentary on the Link between Initial Depression and Anxiety and Long-Term Health Outcomes in Parkinson's Disease Patients".
  Dahodwala N, Weintraub D, Cho HR, Caspell-Garcia C, Dobkin RD Movement disorders clinical practice. 2024 Dec;11(12):1648-1649 Epub 2024 Oct 21;
• Parkinsonism Associated with Anti-B-Cell Maturation Antigen Chimeric Antigen Receptor T-Cell Therapy.
  Schneider S, Aamodt WW, Pruitt AA, Berger JR Movement disorders clinical practice. 2024 Dec;11(12):1625-1628 Epub 2024 Oct 21;
• End-of-Life Health Care Service Use and Cost Among Medicare Decedents With Neurodegenerative Diseases.
  Aamodt WW, Sun C, Dahodwala N, Elser H, Schneider ALC, Farrar JT, Coe NB, Willis AW Neurology. 2024 Nov 12;103(9):e209925 Epub 2024 Oct 11;
• Measurement of α-synuclein as protein cargo in plasma extracellular vesicles.
  Gilboa T, Ter-Ovanesyan D, Wang SC, Whiteman S, Kannarkat GT, Church GM, Chen-Plotkin AS, Walt DR Proceedings of the National Academy of Sciences of the United States of America. 2024 Nov 5;121(45):e2408949121 Epub 2024 Oct 30;
• Correction: Network proteomics of the Lewy body dementia brain reveals presynaptic signatures distinct from Alzheimer's disease.
  Shantaraman A, Dammer EB, Ugochukwu O, Duong DM, Yin L, Carter EK, Gearing M, Chen-Plotkin A, Lee EB, Trojanowski JQ, Bennett DA, Lah JJ, Levey AI, Seyfried NT, Higginbotham L Molecular neurodegeneration. 2024 Oct 11;19(1):71;
• Connecting dementia risk loci to the CSF proteome identifies pathophysiological leads for dementia.
  Reus LM, Jansen IE, Tijms BM, Visser PJ, Tesi N, van der Lee SJ, Vermunt L, Peeters CFW, De Groot LA, Hok-A-Hin YS, Chen-Plotkin A, Irwin DJ, Hu WT, Meeter LH, van Swieten JC, Holstege H, Hulsman M, Lemstra AW, Pijnenburg YAL, van der Flier WM, Teunissen CE, Del Campo Milan M Brain : a journal of neurology. 2024 Oct 3;147(10):3522-3533;
• Improving Parkinson's Disease Care through Systematic Screening for Depression.
  Marras C, Meyer Z, Liu H, Luo S, Mantri S, Allen A, Baybayan S, Beck JC, Brown AE, Cheung F, Dahodwala N, Davis TL, Engeland M, Fearon C, Jones N, Mills K, Miyasaki JM, Naito A, Neault M, Nelson EC, Onyinanya E, Ropa C, Weintraub D Movement disorders clinical practice. 2024 Oct;11(10):1212-1222 Epub 2024 Jul 19;
• Biomarker discovery in progressive supranuclear palsy from human cerebrospinal fluid.
  Jang Y, Oh S, Hall AJ, Zhang Z, Tropea TF, Chen-Plotkin A, Rosenthal LS, Dawson TM, Na CH, Pantelyat AY Clinical proteomics. 2024 Sep 28;21(1):56;
• Neuronal alpha-Synuclein Disease integrated staging system performance in PPMI, PASADENA, and SPARK baseline cohorts.
  Dam T, Pagano G, Brumm MC, Gochanour C, Poston KL, Weintraub D, Chahine LM, Coffey C, Tanner CM, Kopil CM, Xiao Y, Chowdhury S, Concha-Marambio L, DiBiaso P, Foroud T, Frasier M, Jennings D, Kieburtz K, Merchant K, Mollenhauer B, Montine TJ, Nudelman K, Seibyl J, Sherer T, Singleton A, Stephenson D, Stern M, Soto C, Tolosa E, Siderowf A, Dunn B, Simuni T, Marek K, Parkinson’s Progression Markers Initiative NPJ Parkinson's disease. 2024 Sep 27;10(1):178;
• Parkinson's disease is characterized by vitamin B6-dependent inflammatory kynurenine pathway dysfunction.
  Wilson E, Umans J, Swarovski M, Minhas P, Midttun Ø, Ulvik AA, Shahid-Besanti M, Linortner P, Mhatre S, Wang Q, Channappa D, Corso N, Tian L, Fredericks C, Kerchner G, Plowey E, Cholerton B, Ueland P, Zabetian C, Gray N, Quinn J, Montine T, Sha S, Longo F, Wolk D, Chen-Plotkin A, Henderson V, Wyss-Coray T, Wagner A, Mormino E, Aghaeepour N, Poston K, Andreasson K Research square. 2024 Sep 26;
• Reasons for Hospitalizations and Emergency Department Visits Among Patients with Essential Tremor.
  Howard S, Gabriel E, Karsalia R, Macaluso D, Hsu JY, Qiu L, Malhotra NR, Cajigas I, Aamodt W, Farrar J Tremor and other hyperkinetic movements (New York, N.Y.). 2024;14:47 Epub 2024 Sep 23;
• α-Synuclein Conformations in Plasma Distinguish Parkinson's Disease from Dementia with Lewy Bodies.
  Kannarkat GT, Zack R, Skrinak RT, Morley JF, Davila-Rivera R, Arezoumandan S, Dorfmann K, Luk K, Wolk DA, Weintraub D, Tropea TF, Lee EB, Xie SX, Chandrasekaran G, Lee VM, Irwin D, Akhtar RS, Chen-Plotkin AS Research square. 2024 Sep 17;
• Long-Term Dementia Risk in Parkinson Disease.
  Gallagher J, Gochanour C, Caspell-Garcia C, Dobkin RD, Aarsland D, Alcalay RN, Barrett MJ, Chahine L, Chen-Plotkin AS, Coffey CS, Dahodwala N, Eberling JL, Espay AJ, Leverenz JB, Litvan I, Mamikonyan E, Morley J, Richard IH, Rosenthal L, Siderowf AD, Simuni T, York MK, Willis AW, Xie SX, Weintraub D, Parkinson's Progression Markers Initiative Neurology. 2024 Sep 10;103(5):e209699 Epub 2024 Aug 7;
• Social Determinants of Health in Idiopathic Intracranial Hypertension.
  Markowitz D, Aamodt WW, Hamedani AG Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society. 2024 Sep 1;44(3):346-349 Epub 2024 Jan 3;
• Association of Baseline Depression and Anxiety with Longitudinal Health Outcomes in Parkinson's Disease.
  Shi Y, Dobkin R, Weintraub D, Cho HR, Caspell-Garcia C, Bock M, Brown E, Aarsland D, Dahodwala N Movement disorders clinical practice. 2024 Sep;11(9):1103-1112 Epub 2024 Jun 22;
• Large-scale CSF proteome profiling identifies biomarkers for accurate diagnosis of Frontotemporal Dementia.
  Hok-A-Hin YS, Vermunt L, Peeters CFW, van der Ende EL, de Boer SCM, Meeter LH, van Swieten JC, Hu WT, Lleó A, Alcolea D, Engelborghs S, Sieben A, Chen-Plotkin A, Irwin DJ, van der Flier WM, Pijnenburg YAL, Teunissen CE, Del Campo M medRxiv : the preprint server for health sciences. 2024 Aug 20;
• Network proteomics of the Lewy body dementia brain reveals presynaptic signatures distinct from Alzheimer's disease.
  Shantaraman A, Dammer EB, Ugochukwu O, Duong DM, Yin L, Carter EK, Gearing M, Chen-Plotkin A, Lee EB, Trojanowski JQ, Bennett DA, Lah JJ, Levey AI, Seyfried NT, Higginbotham L Molecular neurodegeneration. 2024 Aug 6;19(1):60;
• Validation of the International Classification of Diseases, Tenth Revision-Clinical Modification Diagnostic Code for Essential Tremor.
  Howard SD, Singh S, Macaluso D, Cajigas I, Aamodt WW, Farrar JT Tremor and other hyperkinetic movements (New York, N.Y.). 2024;14:34 Epub 2024 Jul 4;
• Disease Progression and Sphingolipids and Neurofilament Light Chain in Early Idiopathic Parkinson's Disease.
  Couto B, Sousa M, Gonzalez-Latapi P, McArthur E, Lang A, Chen-Plotkin A, Marras C The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques. 2024 Jul;51(4):573-576 Epub 2023 Aug 29;
• Using a smartwatch and smartphone to assess early Parkinson's disease in the WATCH-PD study over 12 months.
  Adams JL, Kangarloo T, Gong Y, Khachadourian V, Tracey B, Volfson D, Latzman RD, Cosman J, Edgerton J, Anderson D, Best A, Kostrzebski MA, Auinger P, Wilmot P, Pohlson Y, Jensen-Roberts S, Müller MLTM, Stephenson D, Dorsey ER, Parkinson Study Group Watch-PD Study Investigators and Collaborators NPJ Parkinson's disease. 2024 Jun 12;10(1):112;
• GPNMB Biomarker Levels in GBA1 Carriers with Lewy Body Disorders.
  Brody EM, Seo Y, Suh E, Amari N, Hartstone WG, Skrinak RT, Zhang H, Diaz-Ortiz ME, Weintraub D, Tropea TF, Van Deerlin VM, Chen-Plotkin AS Movement disorders : official journal of the Movement Disorder Society. 2024 Jun;39(6):1065-1070 Epub 2024 Apr 12;
• Pathologic and cognitive correlates of plasma biomarkers in neurodegenerative disease.
  Cousins KAQ, Phillips JS, Das SR, O'Brien K, Tropea TF, Chen-Plotkin A, Shaw LM, Nasrallah IM, Mechanic-Hamilton D, McMillan CT, Irwin DJ, Lee EB, Wolk DA Alzheimer's & dementia : the journal of the Alzheimer's Association. 2024 Jun;20(6):3889-3905 Epub 2024 Apr 21;
• Medial temporal lobe gray matter microstructure in preclinical Alzheimer's disease.
  Brown C, Das S, Xie L, Nasrallah I, Detre J, Chen-Plotkin A, Shaw L, McMillan C, Yushkevich P, Wolk D Alzheimer's & dementia : the journal of the Alzheimer's Association. 2024 Jun;20(6):4147-4158 Epub 2024 May 15;
• α-Synuclein Conformations in Plasma Distinguish Parkinson's Disease from Dementia with Lewy Bodies.
  Kannarkat GT, Zack R, Skrinak RT, Morley JF, Davila-Rivera R, Arezoumandan S, Dorfmann K, Luk K, Wolk DA, Weintraub D, Tropea TF, Lee EB, Xie SX, Chandrasekaran G, Lee VM, Irwin D, Akhtar RS, Chen-Plotkin AS bioRxiv : the preprint server for biology. 2024 May 8;
• Genetic and phenotypic characterization of Parkinson's disease at the clinic-wide level.
  Tropea TF, Hartstone W, Amari N, Baum D, Rick J, Suh E, Zhang H, Paul RA, Han N, Zack R, Brody EM, Albuja I, James J, Spindler M, Deik A, Aamodt WW, Dahodwala N, Hamedani A, Lasker A, Hurtig H, Stern M, Weintraub D, Vaswani P, Willis AW, Siderowf A, Xie SX, Van Deerlin V, Chen-Plotkin AS NPJ Parkinson's disease. 2024 May 3;10(1):97;
• Disparities in Genetic Testing for Neurologic Disorders.
  Baldwin A, Copeland J, Azage M, Dratch L, Johnson K, Paul RA, Amado DA, Baer M, Deik A, Elman LB, Guo M, Hamedani AG, Irwin DJ, Lasker A, Orthmann-Murphy J, Quinn CC, Tropea TF, Scherer SS, Shinohara RT, Hamilton RH, Ellis CA Neurology. 2024 Mar 26;102(6):e209161 Epub 2024 Mar 6;
• A structured, journal-led peer-review mentoring program enhances peer review training.
  Lyons-Warren AM, Aamodt WW, Pieper KM, Strowd RE Research integrity and peer review. 2024 Mar 8;9(1):3;
• Caregiver Burden in Parkinson Disease: A Scoping Review of the Literature from 2017-2022.
  Aamodt WW, Kluger BM, Mirham M, Job A, Lettenberger SE, Mosley PE, Seshadri S Journal of geriatric psychiatry and neurology. 2024 Mar;37(2):96-113 Epub 2023 Aug 8;
• Novel computerized measure of apathy associates with care partner burden and instrumental activities of daily living in Parkinson's disease.
  Liu J, Massimo L, McMillan CT, Dahodwala N Parkinsonism & related disorders. 2024 Mar;120:105983 Epub 2024 Jan 3;
• Tau maturation in the clinicopathological spectrum of Lewy body and Alzheimer's disease.
  Arezoumandan S, Cousins KAQ, Ohm DT, Lowe M, Chen M, Gee J, Phillips JS, McMillan CT, Luk KC, Deik A, Spindler MA, Tropea TF, Weintraub D, Wolk DA, Grossman M, Lee V, Chen-Plotkin AS, Lee EB, Irwin DJ Annals of clinical and translational neurology. 2024 Mar;11(3):673-685 Epub 2024 Jan 23;
• Efficacy and Safety of DaxibotulinumtoxinA for Injection in Cervical Dystonia: ASPEN-1 Phase 3 Randomized Controlled Trial.
  Comella CL, Jankovic J, Hauser RA, Patel AT, Banach MD, Ehler E, Vitarella D, Rubio RG, Gross TM, ASPEN-1 Study Group Neurology. 2024 Feb 27;102(4):e208091 Epub 2024 Jan 31;
• Genetic testing in adults with neurologic disorders: indications, approach, and clinical impacts.
  Dratch L, Azage M, Baldwin A, Johnson K, Paul RA, Bardakjian TM, Michon SC, Amado DA, Baer M, Deik AF, Elman LB, Gonzalez-Alegre P, Guo MH, Hamedani AG, Irwin DJ, Lasker A, Orthmann-Murphy J, Quinn C, Tropea TF, Scherer SS, Ellis CA Journal of neurology. 2024 Feb;271(2):733-747 Epub 2023 Oct 27;
• Evaluation of ATN(PD) Framework and Biofluid Markers to Predict Cognitive Decline in Early Parkinson Disease.
  Cousins KAQ, Irwin DJ, Tropea TF, Rhodes E, Phillips J, Chen-Plotkin AS, Brumm MC, Coffey CS, Kang JH, Simuni T, Foroud TM, Toga AW, Tanner CM, Kieburtz KD, Mollenhauer B, Galasko D, Hutten S, Weintraub D, Siderowf AD, Marek K, Poston KL, Shaw LM, Parkinson's Progression Markers Initiative Neurology. 2024 Feb;102(4):e208033 Epub 2024 Feb 2;
• Network Proteomics of the Lewy Body Dementia Brain Reveals Presynaptic Signatures Distinct from Alzheimer's Disease.
  Shantaraman A, Dammer EB, Ugochukwu O, Duong DM, Yin L, Carter EK, Gearing M, Chen-Plotkin A, Lee EB, Trojanowski JQ, Bennett DA, Lah JJ, Levey AI, Seyfried NT, Higginbotham L bioRxiv : the preprint server for biology. 2024 Jan 24;
• Ethnoracial differences for caregiving burden in Parkinson's disease.
  Bayram E, Liu H, Luo S, Di Luca DG, Skipworth M, Damron Solomon L, Dahodwala N, Litvan I Parkinsonism & related disorders. 2024 Jan;118:105927 Epub 2023 Nov 7;
• Tremor in cervical dystonia.
  Beylergil SB, Mukunda KN, Elkasaby M, Perlmutter JS, Factor S, Bäumer T, Feurestein J, Shelton E, Bellows S, Jankovic J, Mahajan A, Wamer-Rosen T, Reich SG, Wagle Shukla A, Malaty I, Espay A, Duque K, LeDoux MS, Saunders-Pullman R, Leaver K, Frank S, Pantelyat A, Fung V, Richardson SP, Berman B, Stover N, Deik A, Ondo W, Groth C, Jinnah HA, Shaikh AG Dystonia (Lausanne, Switzerland). 2024;3 Epub 2024 Mar 21;
• Spirituality and Spiritual Distress in Parkinson's Disease Caregivers: A Scoping Review.
  Seshadri S, Sugiura K, Mirham M, Aamodt WW, Kluger BM Journal of religion and health. 2023 Dec;62(6):4222-4243 Epub 2023 Sep 13;
• CSF proteomics in autosomal dominant Alzheimer's disease highlights parallels with sporadic disease.
  van der Ende EL, In 't Veld SGJG, Hanskamp I, van der Lee S, Dijkstra JIR, Hok-A-Hin YS, Blujdea ER, van Swieten JC, Irwin DJ, Chen-Plotkin A, Hu WT, Lemstra AW, Pijnenburg YAL, van der Flier WM, Del Campo M, Teunissen CE, Vermunt L Brain : a journal of neurology. 2023 Nov 2;146(11):4495-4507;
• Alzheimer Disease Biomarkers: Moving from CSF to Plasma for Reliable Detection of Amyloid and tau Pathology.
  Kang JH, Korecka M, Lee EB, Cousins KAQ, Tropea TF, Chen-Plotkin AA, Irwin DJ, Wolk D, Brylska M, Wan Y, Shaw LM Clinical chemistry. 2023 Nov 2;69(11):1247-1259;
• Clinical Reasoning: A 48-Year-Old Man With Spasticity and Progressive Ataxia.
  Vizcarra JA, Paul RA, Hamedani AG, Lynch DR, Aamodt WW Neurology. 2023 Oct 24;101(17):e1747-e1752 Epub 2023 Aug 18;
• Unique characteristics of end-of-life hospitalizations in Parkinson disease.
  Aamodt WW, Dahodwala N, Bilker WB, Farrar JT, Willis AW Frontiers in aging neuroscience. 2023;15:1254969 Epub 2023 Oct 12;
• Testing for Allele-specific Expression from Human Brain Samples.
  Diaz-Ortiz ME, Jain N, Gallagher MD, Posavi M, Unger TL, Chen-Plotkin AS Bio-protocol. 2023 Oct 5;13(19):e4832;
• Weight and survival after deep brain stimulation for Parkinson's disease.
  Eisinger RS, Okun MS, Cernera S, Cagle J, Beke M, Ramirez-Zamora A, Kim BH, Barbosa DAN, Qiu L, Vaswani P, Aamodt WW, Halpern CH, Foote KD, Gunduz A, Almeida L Parkinsonism & related disorders. 2023 Oct;115:105810 Epub 2023 Aug 18;
• CSF proteome profiling reveals biomarkers to discriminate dementia with Lewy bodies from Alzheimer´s disease.
  Del Campo M, Vermunt L, Peeters CFW, Sieben A, Hok-A-Hin YS, Lleó A, Alcolea D, van Nee M, Engelborghs S, van Alphen JL, Arezoumandan S, Chen-Plotkin A, Irwin DJ, van der Flier WM, Lemstra AW, Teunissen CE Nature communications. 2023 Sep 13;14(1):5635;
• User and Usability Testing of a Web-Based Genetics Education Tool for Parkinson Disease: Mixed Methods Study.
  Han N, Paul RA, Bardakjian T, Kargilis D, Bradbury AR, Chen-Plotkin A, Tropea TF JMIR bioinformatics and biotechnology. 2023 Aug 30;4:e45370;
• Sociodemographic and Geographic Disparities in End-of-Life Health Care Intensity Among Medicare Beneficiaries With Parkinson Disease.
  Aamodt WW, Bilker WB, Willis AW, Farrar JT Neurology. Clinical practice. 2023 Aug;13(4):e200171 Epub 2023 May 25;
• Association of Caregiver Depression Risk With Patient Outcomes in Parkinson Disease.
  Rashid R, Aamodt WW, Horn S, Dahodwala N JAMA network open. 2023 Aug 1;6(8):e2327485;
• Validation of the Rainbow Model of Integrated Care Measurement Tool in Parkinson's Disease.
  Valentijn PP, Eggers C, Bloem BR, Grimes D, Goldman J, McGinley J, Gardner J, Piemonte MEP, Dahodwala N, Brennan L, Iansek R, Kovacs N, Parashos S, Hilel A, Rajan R, MDS Study Group on Management of Movement Disorders: Interdisciplinary and Integrated Care Movement disorders : official journal of the Movement Disorder Society. 2023 Jul;38(7):1253-1261 Epub 2023 May 6;
• Scales for Antipsychotic-Associated Movement Disorders: Systematic Review, Critique, and Recommendations.
  Martino D, Karnik V, Bhidayasiri R, Hall DA, Hauser RA, Macerollo A, Pringsheim TM, Truong D, Factor SA, Skorvanek M, Schrag A, Members of the IPMDS Rating Scales Review Committee Movement disorders : official journal of the Movement Disorder Society. 2023 Jun;38(6):1008-1026 Epub 2023 Apr 20;
• Pathological combinations in neurodegenerative disease are heterogeneous and disease-associated.
  Robinson JL, Xie SX, Baer DR, Suh E, Van Deerlin VM, Loh NJ, Irwin DJ, McMillan CT, Wolk DA, Chen-Plotkin A, Weintraub D, Schuck T, Lee VMY, Trojanowski JQ, Lee EB Brain : a journal of neurology. 2023 Jun 1;146(6):2557-2569;
• Racial and Ethnic Differences in Health-Related Quality of Life for Individuals With Parkinson Disease Across Centers of Excellence.
  Di Luca DG, Luo S, Liu H, Cohn M, Davis TL, Ramirez-Zamora A, Rafferty M, Dahodwala N, Naito A, Neault M, Beck J, Marras C Neurology. 2023 May 23;100(21):e2170-e2181 Epub 2023 Apr 5;
• Cognitive heterogeneity in Parkinson's disease: A mechanistic view.
  Carceles-Cordon M, Weintraub D, Chen-Plotkin AS Neuron. 2023 May 17;111(10):1531-1546 Epub 2023 Apr 6;
• Cerebrospinal fluid biomarker panel of synaptic dysfunction in Alzheimer's disease and other neurodegenerative disorders.
  Nilsson J, Cousins KAQ, Gobom J, Portelius E, Chen-Plotkin A, Shaw LM, Grossman M, Irwin DJ, Trojanowski JQ, Zetterberg H, Blennow K, Brinkmalm A Alzheimer's & dementia : the journal of the Alzheimer's Association. 2023 May;19(5):1775-1784 Epub 2022 Oct 14;
• Concomitant Alzheimer Disease Pathology in Parkinson Disease Dementia.
  Tropea TF, Albuja I, Cousins KAQ, Irwin DJ, Lee EB, Chen-Plotkin AS Annals of neurology. 2023 May;93(5):1045-1046 Epub 2023 Mar 16;
• Plasma GFAP associates with secondary Alzheimer's pathology in Lewy body disease.
  Cousins KAQ, Irwin DJ, Chen-Plotkin A, Shaw LM, Arezoumandan S, Lee EB, Wolk DA, Weintraub D, Spindler M, Deik A, Grossman M, Tropea TF Annals of clinical and translational neurology. 2023 May;10(5):802-813 Epub 2023 Mar 31;
• Potential Benefits and Perils of Incorporating ChatGPT to the Movement Disorders Clinic.
  Deik A Journal of movement disorders. 2023 May;16(2):158-162 Epub 2023 May 24;
• Gasdermin-E mediates mitochondrial damage in axons and neurodegeneration.
  Neel DV, Basu H, Gunner G, Bergstresser MD, Giadone RM, Chung H, Miao R, Chou V, Brody E, Jiang X, Lee E, Watts ME, Marques C, Held A, Wainger B, Lagier-Tourenne C, Zhang YJ, Petrucelli L, Young-Pearse TL, Chen-Plotkin AS, Rubin LL, Lieberman J, Chiu IM Neuron. 2023 Apr 19;111(8):1222-1240.e9 Epub 2023 Mar 13;
• Using a smartwatch and smartphone to assess early Parkinson's disease in the WATCH-PD study.
  Adams JL, Kangarloo T, Tracey B, O'Donnell P, Volfson D, Latzman RD, Zach N, Alexander R, Bergethon P, Cosman J, Anderson D, Best A, Severson J, Kostrzebski MA, Auinger P, Wilmot P, Pohlson Y, Waddell E, Jensen-Roberts S, Gong Y, Kilambi KP, Herrero TR, Ray Dorsey E, Parkinson Study Group Watch-PD Study Investigators and Collaborators NPJ Parkinson's disease. 2023 Apr 17;9(1):64;
• Racial and Ethnic Disparities in Parkinson Disease: A Call to Action.
  Aamodt WW, Willis AW, Dahodwala N Neurology. Clinical practice. 2023 Apr;13(2):e200138 Epub 2023 Mar 16;
• The Impact of the COVID-19 Pandemic on Care Partners of People with Parkinson's Disease.
  Speelberg DHB, Hulshoff MJ, Book E, Dahodwala N, Korell M, Tanner CM, Marras C Movement disorders clinical practice. 2023 Apr;10(4):596-605 Epub 2023 Mar 11;
• Plasma phosphorylated tau181 predicts cognitive and functional decline.
  Tropea TF, Waligorska T, Xie SX, Nasrallah IM, Cousins KAQ, Trojanowski JQ, Grossman M, Irwin DJ, Weintraub D, Lee EB, Wolk DA, Chen-Plotkin AS, Shaw LM, Alzheimer's Disease Neuroimaging Initiative Annals of clinical and translational neurology. 2023 Jan;10(1):18-31 Epub 2022 Dec 14;
• Parkinson's Pals: A Student-Led Program to Facilitate Intergenerational Connections and Promote Psychosocial Well-Being Among Persons with Parkinson's Disease.
  Garg U, Gujral J, Gandhi OH, Dahodwala N, Goldner LJ, Hughes S, Reichwein S, Zelouf L, Aamodt WW Journal of Parkinson's disease. 2023;13(7):1267-1271;
• CSF Biomarkers of Alzheimer Disease in Patients With Concomitant α-Synuclein Pathology.
  Cousins KAQ, Arezoumandan S, Shellikeri S, Ohm D, Shaw LM, Grossman M, Wolk D, McMillan CT, Chen-Plotkin A, Lee E, Trojanowski JQ, Zetterberg H, Blennow K, Irwin DJ Neurology. 2022 Nov 14;99(20):e2303-e2312;
• RENEWAL: REpurposing study to find NEW compounds with Activity for Lewy body dementia-an international Delphi consensus.
  O'Brien JT, Chouliaras L, Sultana J, Taylor JP, Ballard C, RENEWAL Study Group Alzheimer's research & therapy. 2022 Nov 11;14(1):169;
• Elevated Plasma Phosphorylated Tau 181 in Amyotrophic Lateral Sclerosis.
  Cousins KAQ, Shaw LM, Shellikeri S, Dratch L, Rosario L, Elman LB, Quinn C, Amado DA, Wolk DA, Tropea TF, Chen-Plotkin A, Irwin DJ, Grossman M, Lee EB, Trojanowski JQ, McMillan CT Annals of neurology. 2022 Nov;92(5):807-818 Epub 2022 Aug 17;
• Serial olfactory testing for the diagnosis of prodromal Parkinson's disease in the PARS study.
  Vaswani PA, Morley JF, Jennings D, Siderowf A, Marek K, PARS investigators Parkinsonism & related disorders. 2022 Nov;104:15-20 Epub 2022 Sep 17;
• Distinguishing Frontotemporal Lobar Degeneration Tau From TDP-43 Using Plasma Biomarkers.
  Cousins KAQ, Shaw LM, Chen-Plotkin A, Wolk DA, Van Deerlin VM, Lee EB, McMillan CT, Grossman M, Irwin DJ JAMA neurology. 2022 Nov 1;79(11):1155-1164;
• CSF proteome profiling across the Alzheimer's disease spectrum reflects the multifactorial nature of the disease and identifies specific biomarker panels.
  Del Campo M, Peeters CFW, Johnson ECB, Vermunt L, Hok-A-Hin YS, van Nee M, Chen-Plotkin A, Irwin DJ, Hu WT, Lah JJ, Seyfried NT, Dammer EB, Herradon G, Meeter LH, van Swieten J, Alcolea D, Lleó A, Levey AI, Lemstra AW, Pijnenburg YAL, Visser PJ, Tijms BM, van der Flier WM, Teunissen CE Nature aging. 2022 Nov;2(11):1040-1053 Epub 2022 Nov 10;
• Longitudinal clinical and biomarker characteristics of non-manifesting LRRK2 G2019S carriers in the PPMI cohort.
  Simuni T, Merchant K, Brumm MC, Cho H, Caspell-Garcia C, Coffey CS, Chahine LM, Alcalay RN, Nudelman K, Foroud T, Mollenhauer B, Siderowf A, Tanner C, Iwaki H, Sherer T, Marek K, Parkinson’s Progression Marker Initiative Authors NPJ Parkinson's disease. 2022 Oct 22;8(1):140;
• Study in Parkinson's disease of exercise phase 3 (SPARX3): study protocol for a randomized controlled trial.
  Patterson CG, Joslin E, Gil AB, Spigle W, Nemet T, Chahine L, Christiansen CL, Melanson E, Kohrt WM, Mancini M, Josbeno D, Balfany K, Griffith G, Dunlap MK, Lamotte G, Suttman E, Larson D, Branson C, McKee KE, Goelz L, Poon C, Tilley B, Kang UJ, Tansey MG, Luthra N, Tanner CM, Haus JM, Fantuzzi G, McFarland NR, Gonzalez-Latapi P, Foroud T, Motl R, Schwarzschild MA, Simuni T, Marek K, Naito A, Lungu C, Corcos DM, SPARX3-PSG Investigators Trials. 2022 Oct 6;23(1):855;
• Natural speech markers of Alzheimer's disease co-pathology in Lewy body dementias.
  Shellikeri S, Cho S, Cousins KAQ, Liberman M, Howard E, Balganorth Y, Weintraub D, Spindler M, Deik A, Lee EB, Trojanowski JQ, Irwin D, Wolk D, Grossman M, Nevler N Parkinsonism & related disorders. 2022 Sep;102:94-100 Epub 2022 Aug 6;
• GPNMB confers risk for Parkinson's disease through interaction with α-synuclein.
  Diaz-Ortiz ME, Seo Y, Posavi M, Carceles Cordon M, Clark E, Jain N, Charan R, Gallagher MD, Unger TL, Amari N, Skrinak RT, Davila-Rivera R, Brody EM, Han N, Zack R, Van Deerlin VM, Tropea TF, Luk KC, Lee EB, Weintraub D, Chen-Plotkin AS Science (New York, N.Y.). 2022 Aug 19;377(6608):eabk0637;
• Changing of the Guard: The Neurology® Resident & Fellow Section in 2022 and Beyond.
  Aamodt WW, Fu KA, Lyons-Warren AM Neurology. 2022 Aug 16;99(7):265-266;
• Trial of Cinpanemab in Early Parkinson's Disease.
  Lang AE, Siderowf AD, Macklin EA, Poewe W, Brooks DJ, Fernandez HH, Rascol O, Giladi N, Stocchi F, Tanner CM, Postuma RB, Simon DK, Tolosa E, Mollenhauer B, Cedarbaum JM, Fraser K, Xiao J, Evans KC, Graham DL, Sapir I, Inra J, Hutchison RM, Yang M, Fox T, Budd Haeberlein S, Dam T, SPARK Investigators The New England journal of medicine. 2022 Aug 4;387(5):408-420;
• Trial of Prasinezumab in Early-Stage Parkinson's Disease.
  Pagano G, Taylor KI, Anzures-Cabrera J, Marchesi M, Simuni T, Marek K, Postuma RB, Pavese N, Stocchi F, Azulay JP, Mollenhauer B, López-Manzanares L, Russell DS, Boyd JT, Nicholas AP, Luquin MR, Hauser RA, Gasser T, Poewe W, Ricci B, Boulay A, Vogt A, Boess FG, Dukart J, D'Urso G, Finch R, Zanigni S, Monnet A, Pross N, Hahn A, Svoboda H, Britschgi M, Lipsmeier F, Volkova-Volkmar E, Lindemann M, Dziadek S, Holiga Š, Rukina D, Kustermann T, Kerchner GA, Fontoura P, Umbricht D, Doody R, Nikolcheva T, Bonni A, PASADENA Investigators, Prasinezumab Study Group The New England journal of medicine. 2022 Aug 4;387(5):421-432;
• Plasma MIA, CRP, and Albumin Predict Cognitive Decline in Parkinson's Disease.
  Shen J, Amari N, Zack R, Skrinak RT, Unger TL, Posavi M, Tropea TF, Xie SX, Van Deerlin VM, Dewey RB Jr, Weintraub D, Trojanowski JQ, Chen-Plotkin AS Annals of neurology. 2022 Aug;92(2):255-269 Epub 2022 Jun 7;
• Immune aging in multiple sclerosis is characterized by abnormal CD4 T cell activation and increased frequencies of cytotoxic CD4 T cells with advancing age.
  Zuroff L, Rezk A, Shinoda K, Espinoza DA, Elyahu Y, Zhang B, Chen AA, Shinohara RT, Jacobs D, Alcalay RN, Tropea TF, Chen-Plotkin A, Monsonego A, Li R, Bar-Or A EBioMedicine. 2022 Aug;82:104179 Epub 2022 Jul 19;
• Self- and Partner-Reported Subjective Memory Complaints: Association with Objective Cognitive Impairment and Risk of Decline.
  Zuroff L, Wisse LE, Glenn T, Xie SX, Nasrallah IM, Habes M, Dubroff J, de Flores R, Xie L, Yushkevich P, Doshi J, Davatsikos C, Shaw LM, Tropea TF, Chen-Plotkin AS, Wolk DA, Das S, Mechanic-Hamilton D Journal of Alzheimer's disease reports. 2022;6(1):411-430 Epub 2022 Jul 22;
• Non-tremor motor dysfunction in Lewy body dementias is associated with AD biomarkers.
  Walker IM, Cousins KA, Siderowf A, Duda JE, Morley JF, Dahodwala N, Tropea T, Vaishnavi S, Wolk DA, Chen-Plotkin AS, Shaw LM, Lee EB, Trojanowski JQ, Grossman M, Weintraub D, Irwin DJ Parkinsonism & related disorders. 2022 Jul;100:33-36 Epub 2022 Jun 8;
• Genetic prediction of impulse control disorders in Parkinson's disease.
  Weintraub D, Posavi M, Fontanillas P, Tropea TF, Mamikonyan E, Suh E, Trojanowski JQ, Cannon P, Van Deerlin VM, 23andMe Research Team, Chen-Plotkin AS Annals of clinical and translational neurology. 2022 Jul;9(7):936-949 Epub 2022 Jun 27;
• Quantitative detection of α-Synuclein and Tau oligomers and other aggregates by digital single particle counting.
  Blömeke L, Pils M, Kraemer-Schulien V, Dybala A, Schaffrath A, Kulawik A, Rehn F, Cousin A, Nischwitz V, Willbold J, Zack R, Tropea TF, Bujnicki T, Tamgüney G, Weintraub D, Irwin D, Grossman M, Wolk DA, Trojanowski JQ, Bannach O, Chen-Plotkin A, Willbold D NPJ Parkinson's disease. 2022 Jun 2;8(1):68;
• John Q. Trojanowski, 'tour de force' in neurodegeneration (1946-2022).
  Chen-Plotkin AS Nature neuroscience. 2022 Jun;25(6):675-676;
• Prosodic characteristics of prepausal words produced by patients with neurodegenerative disease.
  Cho S, Agmon G, Shellikeri S, Cousins KAQ, Ash S, Irwin DJ, Spindler M, Deik AF, Elman LB, Quinn C, Liberman M, Grossman M, Nevler N Speech prosody (Urbana, Ill.). 2022 May;2022:120-124;
• Level I PD-MCI Using Global Cognitive Tests and the Risk for Parkinson's Disease Dementia.
  Boel JA, de Bie RMA, Schmand BA, Dalrymple-Alford JC, Marras C, Adler CH, Goldman JG, Tröster AI, Burn DJ, Litvan I, Geurtsen GJ, MDS Study Group Mild Cognitive Impairment in Parkinson's Disease Movement disorders clinical practice. 2022 May;9(4):479-483 Epub 2022 Apr 29;
• Gait abnormalities and non-motor symptoms predict abnormal dopaminergic imaging in presumed drug-induced Parkinsonism.
  Aamodt WW, Dubroff JG, Cheng G, Taylor B, Wood S, Duda JE, Morley JF NPJ Parkinson's disease. 2022 Apr 28;8(1):53;
• Multimarker synaptic protein cerebrospinal fluid panels reflect TDP-43 pathology and cognitive performance in a pathological cohort of frontotemporal lobar degeneration.
  Cervantes González A, Irwin DJ, Alcolea D, McMillan CT, Chen-Plotkin A, Wolk D, Sirisi S, Dols-Icardo O, Querol-Vilaseca M, Illán-Gala I, Santos-Santos MA, Fortea J, Lee EB, Trojanowski JQ, Grossman M, Lleó A, Belbin O Molecular neurodegeneration. 2022 Apr 8;17(1):29;
• Resident & Fellow Rounds: March 2022.
  Strowd RE 3rd, Aamodt W Neurology. 2022 Mar 29;98(13):540-542;
• Signature laminar distributions of pathology in frontotemporal lobar degeneration.
  Ohm DT, Cousins KAQ, Xie SX, Peterson C, McMillan CT, Massimo L, Raskovsky K, Wolk DA, Van Deerlin VM, Elman L, Spindler M, Deik A, Trojanowski JQ, Lee EB, Grossman M, Irwin DJ Acta neuropathologica. 2022 Mar;143(3):363-382 Epub 2022 Jan 8;
• Resident & Fellow Rounds: February 2022.
  Strowd RE 3rd, Aamodt W Neurology. 2022 Feb 22;98(8):327-329;
• Adverse Childhood Experiences in Patients With Neurologic Disease.
  Mendizabal A, Nathan CL, Khankhanian P, Anto M, Clyburn C, Acaba-Berrocal A, Breen L, Dahodwala N Neurology. Clinical practice. 2022 Feb;12(1):60-67;
• Reply to: "Age-Adjusted Serum Neurofilament Predicts Cognitive Decline in Parkinson's Disease (MARK-PD)".
  Aamodt WW, Chen-Plotkin AS Movement disorders : official journal of the Movement Disorder Society. 2022 Feb;37(2):436-437;
• Sex-Related Longitudinal Change of Motor, Non-Motor, and Biological Features in Early Parkinson's Disease.
  Picillo M, LaFontant DE, Bressman S, Caspell-Garcia C, Coffey C, Cho HR, Burghardt EL, Dahodwala N, Saunders-Pullman R, Tanner CM, Amara AW, Parkinson’s Progression Markers Initiative Journal of Parkinson's disease. 2022;12(1):421-436;
• Abnormal B-Cell and Tfh-Cell Profiles in Patients With Parkinson Disease: A Cross-sectional Study.
  Li R, Tropea TF, Baratta LR, Zuroff L, Diaz-Ortiz ME, Zhang B, Shinoda K, Rezk A, Alcalay RN, Chen-Plotkin A, Bar-Or A Neurology(R) neuroimmunology & neuroinflammation. 2022 Mar;9(2) Epub 2021 Dec 26;
• Resident & Fellow Rounds: December 2021.
  Strowd RE 3rd, Aamodt W Neurology. 2021 Dec 14;97(24):1132-1133;
• Hoehn and Yahr Stage and Striatal Dat-SPECT Uptake Are Predictors of Parkinson's Disease Motor Progression.
  Jackson H, Anzures-Cabrera J, Taylor KI, Pagano G, PASADENA Investigators, Prasinezumab Study Group Frontiers in neuroscience. 2021;15:765765 Epub 2021 Dec 13;
• Predictive modeling of spread in adult-onset isolated dystonia: Key properties and effect of tremor inclusion.
  Wang M, Sajobi T, Morgante F, Adler C, Agarwal P, Bäumer T, Berardelli A, Berman BD, Blumin J, Borsche M, Brashear A, Deik A, Duque K, Espay AJ, Ferrazzano G, Feuerstein J, Fox S, Frank S, Hallett M, Jankovic J, LeDoux MS, Leegwater-Kim J, Mahajan A, Malaty IA, Ondo W, Pantelyat A, Pirio-Richardson S, Roze E, Saunders-Pullman R, Suchowersky O, Truong D, Vidailhet M, Shukla AW, Perlmutter JS, Jinnah HA, Martino D European journal of neurology. 2021 Dec;28(12):3999-4009 Epub 2021 Aug 4;
• Neurofilament Light Chain as a Biomarker for Cognitive Decline in Parkinson Disease.
  Aamodt WW, Waligorska T, Shen J, Tropea TF, Siderowf A, Weintraub D, Grossman M, Irwin D, Wolk DA, Xie SX, Trojanowski JQ, Shaw LM, Chen-Plotkin AS Movement disorders : official journal of the Movement Disorder Society. 2021 Dec;36(12):2945-2950 Epub 2021 Sep 4;
• Resident & Fellow Rounds: November 2021.
  Strowd RE 3rd, Aamodt W Neurology. 2021 Nov 30;97(22):1035-1038;
• The commercial genetic testing landscape for Parkinson's disease.
  Cook L, Schulze J, Verbrugge J, Beck JC, Marder KS, Saunders-Pullman R, Klein C, Naito A, Alcalay RN, ClinGen Parkinson's Disease Gene Curation Expert Panel and the MDS Task Force for Recommendations for Genetic Testing in Parkinson's Disease, Clinical Genome Resource (ClinGen) Parkinson's Disease Gene Curation Expert Panel Authors, Movement Society Disorder (MDS) Task Force on Recommendations for Clinical Genetic Testing in Parkinson's Disease Authors Parkinsonism & related disorders. 2021 Nov;92:107-111 Epub 2021 Oct 19;
• Resident & Fellow Rounds: October 2021.
  Strowd RE 3rd, Aamodt W Neurology. 2021 Oct 26;97(17):832-834;
• Sex Hormone-Binding Globulin (SHBG) in Cerebrospinal Fluid Does Not Discriminate between the Main FTLD Pathological Subtypes but Correlates with Cognitive Decline in FTLD Tauopathies.
  Campo MD, Pijnenburg YAL, Chen-Plotkin A, Irwin DJ, Grossman M, Twaalfhoven HAM, Hu WT, Meeter LH, van Swieten J, Vermunt L, Martens F, Heijboer AC, Teunissen CE Biomolecules. 2021 Oct 8;11(10);
• TMEM106B modifies TDP-43 pathology in human ALS brain and cell-based models of TDP-43 proteinopathy.
  Mao F, Robinson JL, Unger T, Posavi M, Amado DA, Elman L, Grossman M, Wolk DA, Lee EB, Van Deerlin VM, Porta S, Lee VMY, Trojanowski JQ, Chen-Plotkin AS Acta neuropathologica. 2021 Oct;142(4):629-642 Epub 2021 Jun 21;
• A Phase II Study to Evaluate the Safety and Efficacy of Prasinezumab in Early Parkinson's Disease (PASADENA): Rationale, Design, and Baseline Data.
  Pagano G, Boess FG, Taylor KI, Ricci B, Mollenhauer B, Poewe W, Boulay A, Anzures-Cabrera J, Vogt A, Marchesi M, Post A, Nikolcheva T, Kinney GG, Zago WM, Ness DK, Svoboda H, Britschgi M, Ostrowitzki S, Simuni T, Marek K, Koller M, Sevigny J, Doody R, Fontoura P, Umbricht D, Bonni A, PASADENA Investigators, Prasinezumab Study Group Frontiers in neurology. 2021;12:705407 Epub 2021 Oct 1;
• Resident & Fellow Rounds: September 2021.
  Strowd RE 3rd, Aamodt W Neurology. 2021 Sep 28;97(13):644-646;
• Effect of Urate-Elevating Inosine on Early Parkinson Disease Progression: The SURE-PD3 Randomized Clinical Trial.
  Parkinson Study Group SURE-PD3 Investigators, Schwarzschild MA, Ascherio A, Casaceli C, Curhan GC, Fitzgerald R, Kamp C, Lungu C, Macklin EA, Marek K, Mozaffarian D, Oakes D, Rudolph A, Shoulson I, Videnovic A, Scott B, Gauger L, Aldred J, Bixby M, Ciccarello J, Gunzler SA, Henchcliffe C, Brodsky M, Keith K, Hauser RA, Goetz C, LeDoux MS, Hinson V, Kumar R, Espay AJ, Jimenez-Shahed J, Hunter C, Christine C, Daley A, Leehey M, de Marcaida JA, Friedman JH, Hung A, Bwala G, Litvan I, Simon DK, Simuni T, Poon C, Schiess MC, Chou K, Park A, Bhatti D, Peterson C, Criswell SR, Rosenthal L, Durphy J, Shill HA, Mehta SH, Ahmed A, Deik AF, Fang JY, Stover N, Zhang L, Dewey RB Jr, Gerald A, Boyd JT, Houston E, Suski V, Mosovsky S, Cloud L, Shah BB, Saint-Hilaire M, James R, Zauber SE, Reich S, Shprecher D, Pahwa R, Langhammer A, LaFaver K, LeWitt PA, Kaminski P, Goudreau J, Russell D, Houghton DJ, Laroche A, Thomas K, McGraw M, Mari Z, Serrano C, Blindauer K, Rabin M, Kurlan R, Morgan JC, Soileau M, Ainslie M, Bodis-Wollner I, Schneider RB, Waters C, Ratel AS, Beck CA, Bolger P, Callahan KF, Crotty GF, Klements D, Kostrzebski M, McMahon GM, Pothier L, Waikar SS, Lang A, Mestre T JAMA. 2021 Sep 14;326(10):926-939;
• Resident & Fellow Rounds: August 2021.
  Strowd RE 3rd, Aamodt W Neurology. 2021 Aug 31;97(9):445-448;
• Are Parkinson's Disease Patients the Ideal Preclinical Population for Alzheimer's Disease Therapeutics?
  Tropea TF, Chen-Plotkin A Journal of personalized medicine. 2021 Aug 25;11(9);
• Of mice and men: What a mouse model of microglial C9ORF72 deficiency does-and does not-tell us about human neurodegenerative diseases.
  Chen-Plotkin AS Neuron. 2021 Jul 21;109(14):2203-2204;
• Non-motor predictors of 36-month quality of life after subthalamic stimulation in Parkinson disease.
  Jost ST, Visser-Vandewalle V, Rizos A, Loehrer PA, Silverdale M, Evans J, Samuel M, Petry-Schmelzer JN, Sauerbier A, Gronostay A, Barbe MT, Fink GR, Ashkan K, Antonini A, Martinez-Martin P, Chaudhuri KR, Timmermann L, Dafsari HS, EUROPAR and the International Parkinson and Movement Disorders Society Non-Motor Parkinson’s Disease Study Group NPJ Parkinson's disease. 2021 Jun 8;7(1):48;
• Hospital Magnet Status Associates With Inpatient Safety in Parkinson Disease.
  Aamodt WW, Travers J, Thibault D, Willis AW The Journal of neuroscience nursing : journal of the American Association of Neuroscience Nurses. 2021 Jun 1;53(3):116-122;
• L1CAM is not associated with extracellular vesicles in human cerebrospinal fluid or plasma.
  Norman M, Ter-Ovanesyan D, Trieu W, Lazarovits R, Kowal EJK, Lee JH, Chen-Plotkin AS, Regev A, Church GM, Walt DR Nature methods. 2021 Jun;18(6):631-634 Epub 2021 Jun 3;
• Current Knowledge on the Evolution of Care Partner Burden, Needs, and Coping in Parkinson's Disease.
  Hulshoff MJ, Book E, Dahodwala N, Tanner CM, Robertson C, Marras C Movement disorders clinical practice. 2021 May;8(4):510-520 Epub 2021 Apr 12;
• Cognitive Profile and Markers of Alzheimer Disease-Type Pathology in Patients With Lewy Body Dementias.
  Howard E, Irwin DJ, Rascovsky K, Nevler N, Shellikeri S, Tropea TF, Spindler M, Deik A, Chen-Plotkin A, Siderowf A, Dahodwala N, Weintraub D, Shaw LM, Trojanowski JQ, Vaishnavi SN, Wolk DA, Mechanic-Hamilton D, Morley JF, Duda JE, Grossman M, Cousins KAQ Neurology. 2021 Apr 6;96(14):e1855-e1864 Epub 2021 Feb 16;
• Neurofilament Light Chain Related to Longitudinal Decline in Frontotemporal Lobar Degeneration.
  Zhang JV, Irwin DJ, Blennow K, Zetterberg H, Lee EB, Shaw LM, Rascovsky K, Massimo L, McMillan CT, Chen-Plotkin A, Elman L, Lee VM, McCluskey L, Toledo JB, Weintraub D, Wolk D, Trojanowski JQ, Grossman M Neurology. Clinical practice. 2021 Apr;11(2):105-116;
• Author Correction: A growth-factor-activated lysosomal K(+) channel regulates Parkinson's pathology.
  Wie J, Liu Z, Song H, Tropea TF, Yang L, Wang H, Liang Y, Cang C, Aranda K, Lohmann J, Yang J, Lu B, Chen-Plotkin AS, Luk KC, Ren D Nature. 2021 Apr;592(7855):E10;
• Efficacy of Nilotinib in Patients With Moderately Advanced Parkinson Disease: A Randomized Clinical Trial.
  Simuni T, Fiske B, Merchant K, Coffey CS, Klingner E, Caspell-Garcia C, Lafontant DE, Matthews H, Wyse RK, Brundin P, Simon DK, Schwarzschild M, Weiner D, Adams J, Venuto C, Dawson TM, Baker L, Kostrzebski M, Ward T, Rafaloff G, Parkinson Study Group NILO-PD Investigators and Collaborators JAMA neurology. 2021 Mar 1;78(3):312-320;
• A growth-factor-activated lysosomal K(+) channel regulates Parkinson's pathology.
  Wie J, Liu Z, Song H, Tropea TF, Yang L, Wang H, Liang Y, Cang C, Aranda K, Lohmann J, Yang J, Lu B, Chen-Plotkin AS, Luk KC, Ren D Nature. 2021 Mar;591(7850):431-437 Epub 2021 Jan 27;
• Resident & Fellow Rounds.
  Strowd RE 3rd, Aamodt W Neurology. 2021 Feb 23;96(8):396-398;
• Patterns and predictors of referrals to allied health services for individuals with Parkinson's disease: A Parkinson's foundation (PF) QII study.
  Roberts AC, Rafferty MR, Wu SS, Miao G, Cubillos F, Simuni T, Parkinson's Foundation Quality Improvement Initiative Investigators Steering Committee Members, PF QII Principal Investigators Parkinsonism & related disorders. 2021 Feb;83:115-122 Epub 2020 Dec 4;
• LRRK2 and survival in progressive supranuclear palsy.
  Chen-Plotkin AS The Lancet. Neurology. 2021 Feb;20(2):83-84 Epub 2020 Dec 17;
• Burden of Parkinson's Disease by Severity: Health Care Costs in the U.S. Medicare Population.
  Dahodwala N, Li P, Jahnke J, Ladage VP, Pettit AR, Kandukuri PL, Bao Y, Zamudio J, Jalundhwala YJ, Doshi JA Movement disorders : official journal of the Movement Disorder Society. 2021 Jan;36(1):133-142 Epub 2020 Oct 8;
• PPP2R5D Genetic Mutations and Early-Onset Parkinsonism.
  Walker IM, Riboldi GM, Drummond P, Saade-Lemus S, Martin-Saavedra JS, Frucht S, Bardakjian TM, Gonzalez-Alegre P, Deik A Annals of neurology. 2021 Jan;89(1):194-195 Epub 2020 Nov 5;
• Low Sustainment of High-Dose Oral Medication Regimens for Advanced Parkinson's Disease in Medicare Beneficiaries.
  Dahodwala N, Jahnke J, Pettit AR, Li P, Ladage VP, Kandukuri PL, Bao Y, Zamudio J, Jalundhwala YJ, Doshi JA Journal of Parkinson's disease. 2021;11(2):675-684;
• Psychometric Properties of the Clinical Dementia Rating Scale Sum of Boxes in Parkinson's Disease.
  Gallagher J, Rick J, Xie SX, Martinez-Martin P, Mamikonyan E, Chen-Plotkin A, Dahodwala N, Morley J, Duda JE, Trojanowski JQ, Siderowf A, Weintraub D Journal of Parkinson's disease. 2021;11(2):737-745;
• Whole Clinic Research Enrollment in Parkinson's Disease: The Molecular Integration in Neurological Diagnosis (MIND) Study.
  Tropea TF, Amari N, Han N, Rick J, Suh E, Akhtar RS, Dahodwala N, Deik A, Gonzalez-Alegre P, Hurtig H, Siderowf A, Spindler M, Stern M, Thenganatt MA, Weintraub D, Willis AW, Van Deerlin V, Chen-Plotkin A Journal of Parkinson's disease. 2021;11(2):757-765;

See full pubmed publications list